Table of Content 1 IBS-C Drug Market Overview 1.1 Product Overview 1.2 Market Segmentation 1.2.1 Market by Types 1.2.2 Market by Applications 1.2.3 Market by Regions 1.3 Global IBS-C Drug Market Size (2018-2028) 1.3.1 Global IBS-C Drug Revenue ($) and Growth Rate (2018-2028) 1.3.2 Global IBS-C Drug Sales Volume and Growth Rate (2018-2028) 1.4 Research Method and Logic 1.4.1 Research Method 1.4.2 Research Data Source 2 Global IBS-C Drug Market Historic Revenue ($) and Sales Volume Segment by Type 2.1 Global IBS-C Drug Historic Revenue ($) by Type (2018-2023) 2.2 Global IBS-C Drug Historic Sales Volume by Type (2018-2023) 2.3 Linaclotide Sales and Price (2018-2023) 2.4 Lubiprostone Sales and Price (2018-2023) 2.5 Osmotic Laxatives Sales and Price (2018-2023) 2.6 Stimulant Laxatives Sales and Price (2018-2023) 2.7 Others Sales and Price (2018-2023) 3 Global IBS-C Drug Historic Revenue ($) and Sales Volume by Application (2018-2023) 3.1 Global IBS-C Drug Historic Revenue ($) by Application (2018-2023) 3.2 Global IBS-C Drug Historic Sales Volume by Application (2018-2023) 3.3 Hospital Pharmacies Sales, Revenue and Growth Rate (2018-2023) 3.4 Retail Pharmacies Sales, Revenue and Growth Rate (2018-2023) 3.5 Online Pharmacies Sales, Revenue and Growth Rate (2018-2023) 4 Market Dynamic and Trends 4.1 Industry Development Trends under Global Inflation 4.2 Impact of Russia and Ukraine War 4.3 Driving Factors for IBS-C Drug Market 4.4 Factors Challenging the Market 4.5 Opportunities 4.6 Risk Analysis 4.7 Industry News and Policies by Regions 4.7.1 IBS-C Drug Industry News 4.7.2 IBS-C Drug Industry Policies 5 Global IBS-C Drug Market Revenue ($) and Sales Volume by Major Regions 5.1 Global IBS-C Drug Sales Volume by Region (2018-2023) 5.2 Global IBS-C Drug Market Revenue ($) by Region (2018-2023) 6 Global IBS-C Drug Import Volume and Export Volume by Major Regions 6.1 Global IBS-C Drug Import Volume by Region (2018-2023) 6.2 Global IBS-C Drug Export Volume by Region (2018-2023) 7 North America IBS-C Drug Market Current Status (2018-2023) 7.1 Overall Market Size Analysis (2018-2023) 7.1.1 North America IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 7.1.2 North America IBS-C Drug Sales Volume and Growth Rate (2018-2023) 7.2 North America IBS-C Drug Market Trends Analysis Under Global Inflation 7.3 North America IBS-C Drug Sales Volume and Revenue ($) by Country (2018-2023) 7.4 United States 7.4.1 United States IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 7.5 Canada 7.5.1 Canada IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 8 Asia Pacific IBS-C Drug Market Current Status (2018-2023) 8.1 Overall Market Size Analysis (2018-2023) 8.1.1 Asia Pacific IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 8.1.2 Asia Pacific IBS-C Drug Sales Volume and Growth Rate (2018-2023) 8.2 Asia Pacific IBS-C Drug Market Trends Analysis Under Global Inflation 8.3 Asia Pacific IBS-C Drug Sales Volume and Revenue ($) by Country (2018-2023) 8.4 China 8.4.1 China IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 8.5 Japan 8.5.1 Japan IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 8.6 India 8.6.1 India IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 8.7 South Korea 8.7.1 South Korea IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 8.8 Southeast Asia 8.8.1 Southeast Asia IBS-C Drug Revenue ($) by Country (2018-2023) 8.9 Australia 8.9.1 Australia IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9 Europe IBS-C Drug Market Current Status (2018-2023) 9.1 Overall Market Size Analysis (2018-2023) 9.1.1 Europe IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.2.1 Europe IBS-C Drug Sales Volume and Growth Rate (2018-2023) 9.2 Europe IBS-C Drug Market Trends Analysis Under Global Inflation 9.3 Europe IBS-C Drug Sales Volume and Revenue ($) by Country (2018-2023) 9.4 Germany 9.4.1 Germany IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.5 France 9.5.1 France IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.6 United Kingdom 9.6.1 United Kingdom IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.7 Italy 9.7.1 Italy IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.8 Spain 9.8.1 Spain IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.9 Russia 9.9.1 Russia IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 9.10 Poland 9.10.1 Poland IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 10 Latin America IBS-C Drug Market Current Status (2018-2023) 10.1 Overall Market Size Analysis (2018-2023) 10.1.1 Latin America IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 10.1.2 Latin America IBS-C Drug Sales Volume and Growth Rate (2018-2023) 10.2 Latin America IBS-C Drug Market Trends Analysis Under Global Inflation 10.3 Latin America IBS-C Drug Sales Volume and Revenue ($) by Country (2018-2023) 10.4 Mexico 10.4.1 Mexico IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 10.5 Brazil 10.5.1 Brazil IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 10.6 Argentina 10.6.1 Argentina IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 11 Middle East and Africa IBS-C Drug Market Current Status (2018-2023) 11.1 Overall Market Size Analysis (2018-2023) 11.1.1 Middle East and Africa IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 11.2.1 Middle East and Africa IBS-C Drug Sales Volume and Growth Rate (2018-2023) 11.2 Middle East and Africa IBS-C Drug Market Trends Analysis Under Global Inflation 11.3 Middle East and Africa IBS-C Drug Sales Volume and Revenue ($) by Country (2018-2023) 11.4 GCC Countries 11.4.1 GCC Countries IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 11.5 Africa 11.5.1 Africa IBS-C Drug Revenue ($) and Growth Rate (2018-2023) 12 Market Competition Analysis and Key Companies Profiles 12.1 Market Competition by Key Players 12.1.1 Global IBS-C Drug Revenue ($) and Market Share of Key Players 12.1.2 Global IBS-C Drug Sales Volume and Market Share of Key Players 12.1.3 Global IBS-C Drug Average Price by Players 12.1.4 Mergers & Acquisitions, Expansion 12.2 Allergan Market Performance and Business Analysis 12.2.1 Company Profiles 12.2.2 Product Profiles and Application 12.2.3 Allergan Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 12.3 Takeda Market Performance and Business Analysis 12.3.1 Company Profiles 12.3.2 Product Profiles and Application 12.3.3 Takeda Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 12.4 Ardelyx Market Performance and Business Analysis 12.4.1 Company Profiles 12.4.2 Product Profiles and Application 12.4.3 Ardelyx Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 12.5 AMITIZA® (Sucampo Pharmaceuticals) Market Performance and Business Analysis 12.5.1 Company Profiles 12.5.2 Product Profiles and Application 12.5.3 AMITIZA® (Sucampo Pharmaceuticals) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 12.6 Alfsasigma USA, Inc. Market Performance and Business Analysis 12.6.1 Company Profiles 12.6.2 Product Profiles and Application 12.6.3 Alfsasigma USA, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 12.7 Trulance (Synergy Pharmaceuticals Inc.) Market Performance and Business Analysis 12.7.1 Company Profiles 12.7.2 Product Profiles and Application 12.7.3 Trulance (Synergy Pharmaceuticals Inc.) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 12.8 Ironwood Pharmaceuticals Market Performance and Business Analysis 12.8.1 Company Profiles 12.8.2 Product Profiles and Application 12.8.3 Ironwood Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) 13 Value Chain of the IBS-C Drug Market 13.1 Value Chain Status 13.1.1 Value Chain Status Under Global Inflation 13.2 Key Raw Materials and Suppliers 13.2.1 Key Raw Materials Introduction 13.2.2 Key Suppliers of Raw Materials 13.3 Manufacturing Cost Structure Analysis 13.3.1 Production Process Analysis 13.3.2 Manufacturing Cost Structure of IBS-C Drug 13.3.3 Raw Material Cost of IBS-C Drug 13.3.4 Labor Cost of IBS-C Drug 13.4 Major Distributors by Region 13.5 Customer Analysis 14 New Project Feasibility Analysis 14.1 Industry Barriers and New Entrants SWOT Analysis 14.2 Analysis and Suggestions on New Project Investment 15 Global IBS-C Drug Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region 15.1 Global IBS-C Drug Revenue ($) and Sales Volume Forecast by Type (2023-2028) 15.1.1 Global IBS-C Drug Revenue ($) Forecast by Type (2023-2028) 15.1.2 Global IBS-C Drug Sales Volume Forecast by Type (2023-2028) 15.2 Global IBS-C Drug Revenue ($) and Sales Volume Forecast by Application (2023-2028) 15.2.1 Global IBS-C Drug Revenue ($) Forecast by Application (2023-2028) 15.2.2 Global IBS-C Drug Sales Volume Forecast by Application (2023-2028) 15.3 Global IBS-C Drug Sales Volume Forecast by Region (2023-2028) 15.4 Global IBS-C Drug Revenue ($) Forecast by Region (2023-2028) 16 Research Findings and Conclusion

List of Tables and Figures Figure IBS-C Drug Picture Table IBS-C Drug Definition Table Description and Definitions Figure Linaclotide Features Figure Lubiprostone Features Figure Osmotic Laxatives Features Figure Stimulant Laxatives Features Figure Others Features Table Description and Definitions Figure Hospital Pharmacies Figure Retail Pharmacies Figure Online Pharmacies Figure North America IBS-C Drug Revenue ($) and Growth Rate (2018-2028) Figure Asia Pacific IBS-C Drug Revenue ($) and Growth Rate (2018-2028) Figure Europe IBS-C Drug Revenue ($) and Growth Rate (2018-2028) Figure Latin America IBS-C Drug Revenue ($) and Growth Rate (2018-2028) Figure Middle East and Africa IBS-C Drug Revenue ($) and Growth Rate (2018-2028) Figure Global IBS-C Drug Revenue ($) and Growth Rate (2018-2028) Figure Global IBS-C Drug Sales Volume and Growth Rate (2018-2028) Table Global IBS-C Drug Historic Revenue ($) by Type (2018-2023) (Million USD) Table Global IBS-C Drug Historic Revenue ($) Share by Type (2018-2023) Table Global IBS-C Drug Historic Sales Volume by Type (2018-2023) Table Global IBS-C Drug Historic Sales Volume Share by Type (2018-2023) Figure Global Linaclotide Sales and Growth Rate (2018-2023) Figure Global Linaclotide Price (2018-2023) Figure Global Lubiprostone Sales and Growth Rate (2018-2023) Figure Global Lubiprostone Price (2018-2023) Figure Global Osmotic Laxatives Sales and Growth Rate (2018-2023) Figure Global Osmotic Laxatives Price (2018-2023) Figure Global Stimulant Laxatives Sales and Growth Rate (2018-2023) Figure Global Stimulant Laxatives Price (2018-2023) Figure Global Others Sales and Growth Rate (2018-2023) Figure Global Others Price (2018-2023) Table Global IBS-C Drug Historic Revenue ($) by Application (2018-2023) (Million USD) Table Global IBS-C Drug Historic Revenue ($) Share by Application (2018-2023) Table Global IBS-C Drug Historic Sales Volume by Application (2018-2023) (Million USD) Table Global IBS-C Drug Historic Sales Volume Share by Application (2018-2023) Figure Global Hospital Pharmacies Sales and Growth Rate (2018-2023) Figure Global Hospital Pharmacies Revenue and Growth Rate (2018-2023) Figure Global Retail Pharmacies Sales and Growth Rate (2018-2023) Figure Global Retail Pharmacies Revenue and Growth Rate (2018-2023) Figure Global Online Pharmacies Sales and Growth Rate (2018-2023) Figure Global Online Pharmacies Revenue and Growth Rate (2018-2023) Table Industry Development Trends under Global Inflation Table Impact of Russia and Ukraine War Table Driving Factors for IBS-C Drug Market Table Factors Challenging the Market Table Opportunities Table Risk Analysis Table Industry News by Regions Table Industry Policies by Regions Table Global IBS-C Drug Sales Volume by Region (2018-2023) Table Global IBS-C Drug Sales Volume Share by Region (2018-2023) Table Global IBS-C Drug Market Revenue ($) by Region (2018-2023) Table Global IBS-C Drug Market Revenue ($) Share by Region (2018-2023) Table Global IBS-C Drug Import Volume by Region (2018-2023) Table Global IBS-C Drug Export Volume by Region (2018-2023) Figure North America IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure North America IBS-C Drug Sales Volume and Growth Rate (2018-2023) Table North America IBS-C Drug Market Trends Analysis Under Global Inflation Table North America IBS-C Drug Revenue ($) by Country (2018-2023) Table North America IBS-C Drug Sales Volume by Country (2018-2023) Figure United States IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Canada IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Asia Pacific IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Asia Pacific IBS-C Drug Sales Volume and Growth Rate (2018-2023) Table Asia Pacific IBS-C Drug Market Trends Analysis Under Global Inflation Table Asia Pacific IBS-C Drug Revenue ($) by Country (2018-2023) Table Asia Pacific IBS-C Drug Sales Volume by Country (2018-2023) Figure China IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Japan IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure India IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure South Korea IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Table Southeast Asia IBS-C Drug Revenue ($) by Country (2018-2023) Figure Australia IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Europe IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Europe IBS-C Drug Sales Volume and Growth Rate (2018-2023) Table Europe IBS-C Drug Market Trends Analysis Under Global Inflation Table Europe IBS-C Drug Revenue ($) by Country (2018-2023) Table Europe IBS-C Drug Sales Volume by Country (2018-2023) Figure Germany IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure France IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure United Kingdom IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Italy IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Spain IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Russia IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Poland IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Latin America IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Latin America IBS-C Drug Sales Volume and Growth Rate (2018-2023) Table Latin America IBS-C Drug Market Trends Analysis Under Global Inflation Table Latin America IBS-C Drug Revenue ($) by Country (2018-2023) Table Latin America IBS-C Drug Sales Volume by Country (2018-2023) Figure Mexico IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Brazil IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Argentina IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Middle East and Africa IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Middle East and Africa IBS-C Drug Sales Volume and Growth Rate (2018-2023) Table Middle East and Africa IBS-C Drug Market Trends Analysis Under Global Inflation Table Middle East and Africa IBS-C Drug Revenue ($) by Country (2018-2023) Table Middle East and Africa IBS-C Drug Sales Volume by Country (2018-2023) Figure GCC Countries IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Figure Africa IBS-C Drug Revenue ($) and Growth Rate (2018-2023) Table Global IBS-C Drug Revenue ($) of Key Players (2018-2023) Table Global IBS-C Drug Revenue ($) Share of Key Players (2018-2023) Table Global IBS-C Drug Sales Volume of Key Players (2018-2023) Table Global IBS-C Drug Sales Volume Share of Key Players (2018-2023) Table Global IBS-C Drug Average Price of Key Players (2018-2023) Table Mergers & Acquisitions, Expansion Plans Table Allergan Company Profiles Table Product Profiles and Application Table Allergan Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure Allergan Production and Growth Rate Figure Allergan Value ($) Market Share 2018-2023 Table Takeda Company Profiles Table Product Profiles and Application Table Takeda Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure Takeda Production and Growth Rate Figure Takeda Value ($) Market Share 2018-2023 Table Ardelyx Company Profiles Table Product Profiles and Application Table Ardelyx Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure Ardelyx Production and Growth Rate Figure Ardelyx Value ($) Market Share 2018-2023 Table AMITIZA® (Sucampo Pharmaceuticals) Company Profiles Table Product Profiles and Application Table AMITIZA® (Sucampo Pharmaceuticals) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure AMITIZA® (Sucampo Pharmaceuticals) Production and Growth Rate Figure AMITIZA® (Sucampo Pharmaceuticals) Value ($) Market Share 2018-2023 Table Alfsasigma USA, Inc. Company Profiles Table Product Profiles and Application Table Alfsasigma USA, Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure Alfsasigma USA, Inc. Production and Growth Rate Figure Alfsasigma USA, Inc. Value ($) Market Share 2018-2023 Table Trulance (Synergy Pharmaceuticals Inc.) Company Profiles Table Product Profiles and Application Table Trulance (Synergy Pharmaceuticals Inc.) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure Trulance (Synergy Pharmaceuticals Inc.) Production and Growth Rate Figure Trulance (Synergy Pharmaceuticals Inc.) Value ($) Market Share 2018-2023 Table Ironwood Pharmaceuticals Company Profiles Table Product Profiles and Application Table Ironwood Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin) Figure Ironwood Pharmaceuticals Production and Growth Rate Figure Ironwood Pharmaceuticals Value ($) Market Share 2018-2023 Figure Industry Chain Analysis of IBS-C Drug Table Value Chain Status Under Global Inflation Table Key Raw Materials Introduction Table Upstream Raw Material Suppliers of IBS-C Drug with Contact Information Figure Production Process of IBS-C Drug Figure Manufacturing Cost Structure of IBS-C Drug Table Major Distributors of IBS-C Drug with Contact Information Table Major Downstream Buyers of IBS-C Drug with Contact Information Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery Table Global IBS-C Drug Revenue ($) Forecast by Type (2023-2028) (Million USD) Table Global IBS-C Drug Revenue ($) Share Forecast by Type (2023-2028) Table Global IBS-C Drug Sales Volume Forecast by Type (2023-2028) (Million USD) Table Global IBS-C Drug Sales Volume Share Forecast by Type (2023-2028) Table Global IBS-C Drug Revenue ($) Forecast by Application (2023-2028) (Million USD) Table Global IBS-C Drug Revenue ($) Share Forecast by Application (2023-2028) Table Global IBS-C Drug Sales Volume Forecast by Application (2023-2028) (Million USD) Table Global IBS-C Drug Sales Volume Share Forecast by Application (2023-2028) Table Global IBS-C Drug Sales Volume Forecast by Region (2023-2028) Table Global IBS-C Drug Sales Volume Share Forecast by Region (2023-2028) Table Global IBS-C Drug Revenue ($) Forecast by Region (2023-2028) Table Global IBS-C Drug Revenue ($) Share Forecast by Region (2023-2028)